Unknown

Dataset Information

A Novel Staging System for De Novo Metastatic Breast Cancer Refines Prognostic Estimates.


ABSTRACT:

Objective

We aim to identify prognostic groups within a de novo metastatic cohort, incorporating both anatomic and biologic factors.

Background

Staging for breast cancer now includes anatomic and biologic factors, although the guidelines for stage IV disease do not account for how these factors may influence outcomes.

Methods

Adults with de novo metastatic breast cancer were selected from the National Cancer DataBase (2010-2013). Recursive partitioning analysis was used to group patients with similar overall survival (OS) based on clinical T/N stage, tumor grade, ER, PR, HER2, number of metastatic sites, and presence of bone-only metastases. Categories were created by amalgamating homogeneous groups based on 3-year OS rates (stage IVA: >50%, stage IVB: 30%-50%, stage

SUBMITTER: Plichta JK 

PROVIDER: S-EPMC7794098 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature